Yao Z, Gu Y, Zhang Q, Liu L, Meng G, Wu H
The company explains that this structure improves blood glucose control and partially mitigates GLP-1-related gastrointestinal side effects
Cyanocobalamin formulations contain trace amounts of cyanide and are contraindicated in patients with Leber's hereditary optic neuropathy
Intestinal microorganisms metabolize TML into trimethyl-5-aminovaleric acid (TMAVA), which can competitively inhibit the binding of -BB to BBD, thereby inhibiting carnitine biosynthesis and FAO in the liver, promoting steatosis and aggravating fatty liver [250]
No fillers, just research-backed ingredients
For planned surgery, follow your surgical team's instructions regarding your GLP-1 medication